Correlation Between Recursion Pharmaceuticals and LLOYDS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and LLOYDS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and LLOYDS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and LLOYDS BKG GROUP, you can compare the effects of market volatilities on Recursion Pharmaceuticals and LLOYDS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of LLOYDS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and LLOYDS.

Diversification Opportunities for Recursion Pharmaceuticals and LLOYDS

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Recursion and LLOYDS is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and LLOYDS BKG GROUP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LLOYDS BKG GROUP and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with LLOYDS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LLOYDS BKG GROUP has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and LLOYDS go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and LLOYDS

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 10.98 times more return on investment than LLOYDS. However, Recursion Pharmaceuticals is 10.98 times more volatile than LLOYDS BKG GROUP. It trades about 0.03 of its potential returns per unit of risk. LLOYDS BKG GROUP is currently generating about 0.01 per unit of risk. If you would invest  751.00  in Recursion Pharmaceuticals on September 13, 2024 and sell it today you would lose (15.00) from holding Recursion Pharmaceuticals or give up 2.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy90.71%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  LLOYDS BKG GROUP

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
LLOYDS BKG GROUP 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days LLOYDS BKG GROUP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, LLOYDS is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Recursion Pharmaceuticals and LLOYDS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and LLOYDS

The main advantage of trading using opposite Recursion Pharmaceuticals and LLOYDS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, LLOYDS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LLOYDS will offset losses from the drop in LLOYDS's long position.
The idea behind Recursion Pharmaceuticals and LLOYDS BKG GROUP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stocks Directory
Find actively traded stocks across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities